Cargando…
P16 Methylation Leads to Paclitaxel Resistance of Advanced Non-Small Cell Lung Cancer
Paclitaxel-based chemotherapy is widely used as the first-line treatment for non-small cell lung cancer (NSCLC). However, only 20%-40% of patients have shown sensitivity to paclitaxel. This study aimed to investigate whether P16 methylation could be used to predict paclitaxel chemosensitivity of NSC...
Autores principales: | Liu, Zhaojun, Lin, Hongmei, Gan, Ying, Cui, Chenghua, Zhang, Baozhen, Gu, Liankun, Zhou, Jing, Zhu, Guangying, Deng, Dajun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547999/ https://www.ncbi.nlm.nih.gov/pubmed/31205528 http://dx.doi.org/10.7150/jca.26482 |
Ejemplares similares
-
P16-specific DNA methylation by engineered zinc finger methyltransferase inactivates gene transcription and promotes cancer metastasis
por: Cui, Chenghua, et al.
Publicado: (2015) -
Significant impact of amount of PCR input templates on various PCR-based DNA methylation analysis and countermeasure
por: Liu, Zhaojun, et al.
Publicado: (2016) -
CDKN2A Deletion Leading to Hematogenous Metastasis of Human Gastric Carcinoma
por: Qiao, Juanli, et al.
Publicado: (2021) -
Chidamide increases the sensitivity of Non-small Cell Lung Cancer to Crizotinib by decreasing c-MET mRNA methylation
por: Ding, Nan, et al.
Publicado: (2020) -
P16 methylation increases the sensitivity of cancer cells to the CDK4/6 inhibitor palbociclib
por: Li, Paiyun, et al.
Publicado: (2019)